Dow Up 0.12% Nasdaq Down 0.20%

Zogenix, Inc. (ZGNX)

-NasdaqGM
10.50 Down 0.35(3.23%) 9:45AM EST - Nasdaq Real Time Price
Prev Close:10.85
Open:10.75
Bid:10.65 x 1800
Ask:10.75 x 1400
1y Target Est:19.80
Beta:1.96292
Earnings Date:Mar 8 - Mar 13 (Est.)
Day's Range:10.40 - 10.75
52wk Range:7.33 - 13.70
Volume:28,695
Avg Vol (3m):283,684
Market Cap:260.31M
P/E (ttm):N/A
EPS (ttm):-2.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ZGNX

Comparison

Symbol% ChgMkt Cap
ZGNXDown 3.23%260.31M
PFEUp 0.37%204.59B
AZNUp 1.30%72.17B
GSKUp 0.50%97.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.71
Quarterly EPS Est (Dec-16) :-0.84
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback